We detected BCL-W mRNA and protein were as often and as highly expressed as BCL-2 in DLBCL, where BCL-2 has long served as the hallmark of a prognostically unfavorable subset (94). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.